Delivery Order SPE2DB20D3103-SPE2DB25FL4U6

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,725.87 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567617155 TACROLIMUS 1 MG CAPSULE (IR) 100S. The delivery order has an ultimate completion date of March 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing...
This is a firm-fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to Amerisourcebergen Drug Corp in the amount of $1,066.68. The contract is for the supply of 100 capsules of the pharmaceutical product TACROLIMUS 1 MG CAPSULE (IR). This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.57 firm fixed-price delivery order contract covers the supply of Tacrolimus 1 mg capsules (immediate release) to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the supply of Tacrolimus 1 mg capsules. The award is a firm-fixed price contract with a ceiling value of $4,305.10 and an ultimate completion date of November 16, 2021. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major supplier of pharmaceutical products and medical supplies to various federal agencies,...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,310.40 for the supply of Tacrolimus 1 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating an open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,767.09, is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used for various medical treatments. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 100 capsules of 1 mg Tacrolimus, an immunosuppressant drug used to prevent organ rejection. The contract has a potential value of $4,745.90 and a completion date of May 5, 2022. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,417.60 Firm Fixed Price Delivery Order is for the supply of 100 capsules of Tacrolimus 1 mg, an immunosuppressant medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,581.16, is for the delivery of Tacrolimus 1 mg capsules (immediate-release) in 100-count containers. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,925.04, is for the delivery of TACROLIMUS 0.5 MG CAPSULE (IR) 100S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024 and is structured as a Firm Fixed Price Delivery Order. This...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL4U6
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.84, is for the delivery of Tacrolimus 1 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:21 PM